Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
26.56
-0.77 (-2.82%)
Apr 8, 2026, 10:31 AM EDT - Market open

AAPG Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
574.12980.65221.98209.7127.91
Revenue Growth (YoY)
-41.45%341.77%5.85%651.38%124.18%
Cost of Revenue
48.9429.0930.54223.33
Gross Profit
525.18951.57191.44187.7124.58
Selling, General & Admin
599.92383.12376.46328.02191.26
Research & Development
1,137947.25706.97743.1766.49
Other Operating Expenses
73.69.085.217.6750.4
Total Operating Expenses
1,8111,3391,0891,0891,008
Operating Income
-1,286-387.88-897.2-901.08-983.57
Interest Income
0.31-0.281.08-0.28-
Interest Expense
-54.07-64.46-96.06-52.79-16.73
Other Non-Operating Income (Expense)
103.557.3659.3266.97168.06
Total Non-Operating Income (Expense)
49.74-7.38-35.6713.91151.33
Pretax Income
-1,236-395.26-932.86-887.17-832.25
Provision for Income Taxes
-10.43--4.25-49.83
Net Income
-1,243-405.43-925.64-882.92-782.42
Minority Interest in Earnings
-0.22-0.25-0.08--
Net Income to Common
-1,243-405.43-925.64-882.92-782.42
Shares Outstanding (Basic)
8976716664
Shares Outstanding (Diluted)
8976716664
Shares Change (YoY)
17.90%7.00%7.06%3.56%17.93%
EPS (Basic)
-13.96-5.36-13.12-13.40-12.28
EPS (Diluted)
-13.96-5.36-13.12-13.40-12.28
Shares Outstanding
92.9678.8172.5565.9765.72
Free Cash Flow
0-135.65-772.19-857.2-1,036
Free Cash Flow Per Share
--1.80-10.94-13.00-16.28
Gross Margin
91.48%97.03%86.24%89.51%88.08%
Operating Margin
-223.96%-39.55%-404.17%-429.68%-3524.09%
Profit Margin
-216.50%-41.37%-417.02%-421.02%-2803.38%
FCF Margin
0.00%-13.83%-347.86%-408.75%-3712.82%
EBITDA
-1,286-294.71-804-838.17-955.25
EBITDA Margin
-223.96%-30.05%-362.19%-399.68%-3422.60%
EBIT
-1,286-387.88-897.2-901.08-983.57
EBIT Margin
-223.96%-39.55%-404.17%-429.68%-3524.09%
Effective Tax Rate
0.00%-2.64%0.00%0.48%5.99%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q